Senhwa Biosciences, Inc. (6492.TWO)
TWD 35.1
(-9.88%)
TWD 35.1
(-9.88%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -283.78 Million TWD | 13.93% |
| 2022 | -340.6 Million TWD | -2.62% |
| 2021 | -321.58 Million TWD | 3.43% |
| 2020 | -347.01 Million TWD | 8.68% |
| 2019 | -381.2 Million TWD | -0.26% |
| 2018 | -375.29 Million TWD | -3.02% |
| 2017 | -373.37 Million TWD | -45.46% |
| 2016 | -253.03 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -70.46 Million TWD | -10.73% |
| 2024 Q1 | -63.71 Million TWD | 24.46% |
| 2023 Q3 | -76.1 Million TWD | -15.55% |
| 2023 Q1 | -74.65 Million TWD | 18.67% |
| 2023 Q2 | -65.86 Million TWD | 11.77% |
| 2023 Q4 | -83.76 Million TWD | -10.06% |
| 2023 FY | - TWD | 13.93% |
| 2022 Q2 | -97.51 Million TWD | -26.47% |
| 2022 FY | - TWD | -2.62% |
| 2022 Q4 | -91.78 Million TWD | -11.14% |
| 2022 Q3 | -82.59 Million TWD | 15.31% |
| 2022 Q1 | -77.1 Million TWD | 5.63% |
| 2021 FY | - TWD | 3.43% |
| 2021 Q4 | -81.7 Million TWD | 6.94% |
| 2021 Q3 | -87.79 Million TWD | 0.0% |
| 2020 FY | - TWD | 8.68% |
| 2019 FY | - TWD | -0.26% |
| 2018 FY | - TWD | -3.02% |
| 2017 FY | - TWD | -45.46% |
| 2016 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | -513.669% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 172.099% |
| Level Biotechnology Inc. | 98.7 Million TWD | 387.511% |
| Sagittarius Life Science Corp | -44.73 Million TWD | -534.312% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | -293.517% |
| TaiMed Biologics Inc. | -25.23 Million TWD | -1024.658% |
| GlycoNex Incorporation | -126.82 Million TWD | -123.758% |
| VBI | -6.97 Million TWD | -3970.353% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | -97.491% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | 1401.169% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | -1500.953% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | -173.884% |
| Visgeneer Inc. | 973 Thousand TWD | 29265.982% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 16.407% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 130.304% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 384.248% |
| Neith Corporation | -33.61 Million TWD | -744.347% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 71.366% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | -16237.651% |
| Enimmune corporation | -228.96 Million TWD | -23.944% |
| TaiRx, Inc. | -208.64 Million TWD | -36.013% |
| CHO Pharma, Inc. | -277.73 Million TWD | -2.18% |
| EirGenix Inc. | -664.4 Million TWD | 57.287% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 483.991% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | 510.432% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 73.513% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | -150.902% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | 914.585% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | -355.214% |
| Lukas Biomedical Inc. | -26.3 Million TWD | -979.03% |
| RBC Bioscience Corporation | 36.54 Million TWD | 876.493% |
| BiOptic Inc. | 65.03 Million TWD | 536.337% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 58.417% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | -759.798% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | -416.771% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 165.455% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | -254.412% |
| NaviFUS Corp. | -55.79 Million TWD | -408.621% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | -1609.754% |
| Sinew Pharma Inc. | -163.63 Million TWD | -73.43% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | -361.439% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 247.496% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | -25.193% |
| AP Biosciences Inc | -325.51 Million TWD | 12.819% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 72.834% |
| 3D Global Biotech Inc. | -35.84 Million TWD | -691.678% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | 1074.202% |
| Intech Biopharm Corporation | -219.58 Million TWD | -29.237% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 57.91% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | -531.321% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | -76.421% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 143.291% |
| TCI GENE Inc. | 25.98 Million TWD | 1192.279% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | -156.499% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | -94.413% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | 2148.989% |
| PharmaEngine, Inc. | 347.3 Million TWD | 181.71% |
| Savior Lifetec Corporation | 219.6 Million TWD | 229.225% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 264.771% |
| OBI Pharma, Inc. | -855.08 Million TWD | 66.812% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | -206.586% |
| Acepodia, Inc. | -764.51 Million TWD | 62.881% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 38.32% |